B-ALL MRD Flow Panel

Code
FLG-BAMR-03BX
Panel
Active-Compendium
Bone Marrow samples: 88184x1, 88185x13. Peripheral Blood samples: 88184x1, 88185x10. Add 88188x1 for global.
Clinical
Oncology,Pathology
<p>Bone marrow aspirate: 2-3 mL EDTA preferred. Sodium heparin is acceptable.<br/>
Peripheral blood: 5-6 mL EDTA preferred. Sodium heparin is acceptable.<br/>
NY Clients: Please provide Date and Time of Collection.<br/>
Note: Lithium heparin or ACD (pale yellow/no gel separator) is not acceptable. Please provide recent CBC report.</p>
Flag Active
True
Orderable Test Description
Available as global test only. Markers are CD304/CD73, CD45, CD19, CD34, CD38, CD10, CD22, CD58, CD66C/CD123, CD13/CD33, and CD20. Additional markers (CD13, CD14, CD16, CD45, and HLA-DR) are included for bone marrow samples to aid in evaluating the extent of hemodilution in bone marrow aspirates. This panel can detect MRD at the 0.01% level.
Orderable Turn Around Time
24 Hours
Meta Description
In patients with B-lymphoblastic leukemia, a combination of morphology and flow cytometry testing for minimal residual disease (MRD) is recommended when assessing response to therapy.
NY Approved
True
Orderable Biomarkers JSON
{"Flow Cytometry": {"Markers": ["HLA-DR", "CD304/CD73", "CD38", "CD10", "CD22", "CD16", "CD66C/CD123", "CD13/CD33", "CD58", "CD20", "CD19", "CD34", "CD13", "CD14", "CD45"]}}
Keywords string
residual disease, b-all mrd, mrd, b-all, ball, mrd, b-all flow panel B-ALL MRD Flow Panel
Title URL
b-all-mrd-flow-panel
Storage and transportation
Specimens should be received at NeoGenomics within 72 hours from collection to assure sample integrity and acceptable cell viability. Note: New York State samples must be received within 48 hours from collection per NYS requirements. Refrigerate specimen. Do not freeze. Use cold pack for transport, making sure cold pack is not in direct contact with specimen.